Cargando…

Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies

INTRODUCTION: Angiotensin II type 1 receptor antibody (AT1R-Ab), is a non–human leukocyte antigen (HLA) antibody implicated in poor renal allograft outcomes, although its actions may be mediated through a different pathway than HLA donor-specific antibodies (DSAs). Our aim was to examine serum cytok...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pearl, Meghan H., Grotts, Jonathan, Rossetti, Maura, Zhang, Qiuheng, Gjertson, David W., Weng, Patricia, Elashoff, David, Reed, Elaine F., Tsai Chambers, Eileen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451195/ https://www.ncbi.nlm.nih.gov/pubmed/30997435 http://dx.doi.org/10.1016/j.ekir.2018.12.011

Ejemplares similares

Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation
por: Pearl, Meghan H., et al.
Publicado: (2020)

Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor–Intolerant Patients
por: Schaenman, Joanna, et al.
Publicado: (2022)

Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges
por: Locke, Arlene F., et al.
Publicado: (2023)

Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients
por: Ahn, Richard, et al.
Publicado: (2021)

Integrate CRISPR/Cas9 for protein expression of HLA-B*38:68Q via precise gene editing
por: Yin, Yuxin, et al.
Publicado: (2019)

Depression in Nonclassical Hypogonadism in Young Men
por: Korenman, Stanley G, et al.
Publicado: (2018)

Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States
por: Saab, Sammy, et al.
Publicado: (2016)

Commercially Available Angiotensin II At(2) Receptor Antibodies Are Nonspecific
por: Hafko, Roman, et al.
Publicado: (2013)

Angiotensin II Type 1 Receptor Antibody-Mediated Kidney Rejection Unresponsive to Treatment
por: Allison, David, et al.
Publicado: (2023)

Factors associated with retention in Option B+ in Malawi: a case control study
por: Hoffman, Risa M, et al.
Publicado: (2017)

Enhanced Tumor Localization of Monoclonal Antibody by Treatment with Kininase II Inhibitor and Angiotensin II
por: Noguchi, Akinori, et al.
Publicado: (1992)

DNA Methylation Age Is More Closely Associated With Infection Risk Than Chronological Age in Kidney Transplant Recipients
por: Schaenman, Joanna, et al.
Publicado: (2020)

Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients
por: Mba Medie, Felix, et al.
Publicado: (2019)

Antibody therapy can enhance AngiotensinII-induced myocardial fibrosis
por: Rosin, Nicole L, et al.
Publicado: (2014)

Correction: Commercially Available Angiotensin II AT(2) Receptor Antibodies Are Nonspecific
por: Hafko, Roman, et al.
Publicado: (2014)

638. CMV-Specific T-Cell Immune Responses in Older vs. Younger Kidney Transplant Recipients
por: Liang, Emily, et al.
Publicado: (2018)

NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant
por: Pickering, Harry, et al.
Publicado: (2021)

FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines
por: Su, Ke, et al.
Publicado: (2017)

Plasma proteome perturbation for CMV DNAemia in kidney transplantation
por: Sigdel, Tara K., et al.
Publicado: (2023)

Angiotensin II and Renal Tubular Ion Transport
por: Valles, Patricia, et al.
Publicado: (2005)

Differences in Proinflammatory Cytokines and Monocyte Subtypes in Older as Compared With Younger Kidney Transplant Recipients
por: Liang, Emily C., et al.
Publicado: (2018)

Angiotensin II Peptides
por: Izumi, Yasukatsu, et al.
Publicado: (2013)

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease
por: Lee, De-Hyung, et al.
Publicado: (2014)

Angiotensin II Type 1 Receptor Antibodies Trigger Inflammation in Renal Transplantation
por: Philippe, Aurelie
Publicado: (2019)

Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation
por: Philippe, Aurélie, et al.
Publicado: (2022)

Vascular and Non-HLA autoantibody profiles in hospitalized patients with COVID-19
por: Lichtenstein, Brian, et al.
Publicado: (2023)

An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA
por: Thomas, K A, et al.
Publicado: (2015)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018)

Mechanical Stress Triggers Cardiomyocyte Autophagy through Angiotensin II Type 1 Receptor-Mediated p38MAP Kinase Independently of Angiotensin II
por: Lin, Li, et al.
Publicado: (2014)

Proteasome inhibition reduces plasma cell and antibody secretion, but not angiotensin II-induced hypertension
por: Figueiredo Galvao, Hericka Bruna, et al.
Publicado: (2023)

Angiotensin II in septic shock
por: Corrêa, Thiago D, et al.
Publicado: (2015)

Role of angiotensin II in aging
por: Yi, Wenmin, et al.
Publicado: (2022)

SAT-562 Angiotensin II Induces Aldosterone Synthesis in the Rat Heart Stressed by Angiotensin II
por: Bose, Himangshu S, et al.
Publicado: (2020)

Effects of Endogenous Angiotensin II on Abdominal Aortic Aneurysms and Atherosclerosis in Angiotensin II–Infused Mice
por: Kukida, Masayoshi, et al.
Publicado: (2021)

Effect of Angiotensin II on Chondrocyte Degeneration and Protection via Differential Usage of Angiotensin II Receptors
por: Nishida, Takashi, et al.
Publicado: (2021)

RENAL HYPERTENSION IN RATS IMMUNIZED AGAINST ANGIOTENSIN I AND ANGIOTENSIN II
por: Oates, Helen F., et al.
Publicado: (1974)

Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
por: Clark, Michelle A., et al.
Publicado: (2013)

629. Blood Transcriptome Variations Predict Infection and Rejection in the Older Kidney Transplant Recipient
por: Schaenman, Joanna, et al.
Publicado: (2018)

Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection
por: Lee, Hyeyoung, et al.
Publicado: (2015)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
por: Ye, Jing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h1cm6maoaan5ub16e1utd78j95